I have previously mentioned in other forum that holders need to be realistic and not to expect a commercial contract before 2024-2025 I was actually optimistic.
With todays update, its safe to say holders should not expect a commercial contract and revenue before 2027-2028 (this is if all going well and no push backs).
I think EMV has a potential but it is at very very very early stages.
GLTAHs
Ann: Stage 2 of Clinical Trial Activated, page-12
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
-0.060(2.91%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| $2.05 | $2.13 | $1.99 | $251.9K | 123.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9762 | $2.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 2346 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |